Cargando…

Twelve months of follow-up after intravitreal injection of ranibizumab for the treatment of idiopathic parafoveal telangiectasia

AIMS: To report the anatomic and functional outcomes of intravitreal ranibizumab in idiopathic parafoveal telangiectasia (IPT). MATERIAL AND METHODS: Four eyes of three patients were included in this interventional case series. One patient (two eyes) had bilateral IPT (type 2) and two patients (two...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rouvas, Alexandros, Malamos, Panagiotis, Douvali, Maria, Ntouraki, Amalia, Markomichelakis, Nikos N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707419/ https://www.ncbi.nlm.nih.gov/pubmed/23861579 http://dx.doi.org/10.2147/OPTH.S44109

Ejemplares similares

Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization
por: Petrou, Petros, et al.
Publicado: (2013)

Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane
por: Shanmugam, Mahesh P, et al.
Publicado: (2007)

Idiopathic retinal vasculitis, arteriolar macroaneurysms and neuroretinitis: clinical course and treatment
por: Rouvas, Alexander, et al.
Publicado: (2013)

Eccentric Macular Hole after Pars Plana Vitrectomy for Idiopathic Macular Hole: A Case Report
por: Chatziralli, Irini, et al.
Publicado: (2017)

A rare case of idiopathic parafoveal telangiectasia associated with central serous chorioretinopathy
por: Thomas, Nicey Roy, et al.
Publicado: (2017)

Twelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab
por: Sakanishi, Yoshihito, et al.
Publicado: (2016)

Effect of intravitreal aflibercept injection for age-related macular degeneration with a retinal pigment epithelial tear refractory to intravitreal ranibizumab injection
por: Fujii, Ayaka, et al.
Publicado: (2014)

Intravitreal Ranibizumab and Laser Photocoagulation in the Management of Idiopathic Juxtafoveolar Retinal Telangiectasia Type 1: A Case Report
por: Ciarnella, Angela, et al.
Publicado: (2012)

Combined Parafoveal Telangiectasia, Multifocal Central Serous Chorioretinopathy, and Choroidal Hemangioma
por: Nagesha, C. K., et al.
Publicado: (2019)

Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia
por: Aydoğan, Tuğba, et al.
Publicado: (2016)

Preretinal hemorrhage as a presenting sign of idiopathic macular telangiectasia type 2
por: Osher, James M, et al.
Publicado: (2015)

Clinical Efficacy of Intravitreal Ranibizumab in Early and Mid-Idiopathic Choroidal Neovascularization
por: Fan, Chuanfeng, et al.
Publicado: (2014)

A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis
por: Karagiannis, Dimitrios, et al.
Publicado: (2009)

Twelve cases of drug-induced blepharospasm improved within 2 months of psychotropic cessation
por: Emoto, Yuko, et al.
Publicado: (2011)

Foveal atrophy and macular hole formation following intravitreal ranibizumab with/without photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration
por: Rishi, Pukhraj, et al.
Publicado: (2011)

The Role of Fundus Autofluorescence Imaging in the Study of the Course of Posterior Uveitis Disorders
por: Malamos, Panagiotis, et al.
Publicado: (2015)

Rhizobium radiobacter Endophthalmitis following Intravitreal Ranibizumab Injection
por: Joshi, Lavnish, et al.
Publicado: (2012)

Treatment of Radiation Retinopathy with Intravitreal Injection of Ranibizumab (Lucentis(®))
por: Horowitz, Soraya Alessandra, et al.
Publicado: (2020)

Combined intravitreal ranibizumab and posterior subtenon triamcinolone acetonide injections for patients with diabetic macular edema refractory to intravitreal ranibizumab monotherapy
por: Chiu, Chiung-Yi, et al.
Publicado: (2021)

Idiopathic Choroidal Neovascularization: Intraocular Inflammatory Cytokines and the Effect of Intravitreal Ranibizumab Treatment
por: Yin, Houfa, et al.
Publicado: (2016)

Efficacy of Intravitreal Bevacizumab in Treatment of Proliferative Type 2 Idiopathic Juxtafoveal Telangiectasia
por: Baz, Ökkeş, et al.
Publicado: (2017)

Effectiveness of ranibizumab intravitreal injections for exudative age-related macular degeneration treatment: 12-month outcomes
por: Figurska, Małgorzata, et al.
Publicado: (2011)

Intravitreal Ranibizumab Versus Intravitreal Ranibizumab Combined with Posterior Subtenon Triamcinolone Acetonide in Diabetic Macular Edema
por: Karatas, Gamze, et al.
Publicado: (2021)

Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
por: Ellabban, Abdallah A, et al.
Publicado: (2012)

Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab
por: Takayama, Kei, et al.
Publicado: (2012)

Surgically Induced Corneal Astigmatism Following Intravitreal Ranibizumab Injection
por: Kocatürk, Tolga, et al.
Publicado: (2015)

Severe Gemella haemolysans endophthalmitis following ranibizumab intravitreal injection
por: Salceanu, Silvia Olivia, et al.
Publicado: (2017)

Diabetic papillopathy treated with intravitreal ranibizumab
por: Yildirim, Mine, et al.
Publicado: (2017)

Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
por: Jung, Byung Ju, et al.
Publicado: (2019)

Subthreshold Micropulse Yellow Laser (577 nm) for Idiopathic Macular Telangiectasia Type 1 Resistant to Intravitreal Injection
por: Kang, Yong Koo, et al.
Publicado: (2020)

Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab
por: Makri, Olga E, et al.
Publicado: (2018)

A case of late-onset larynx angioedema after ranibizumab intravitreal injection: Ranibizumab-related angioedema
por: De Bernardo, Maddalena, et al.
Publicado: (2020)

Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema
por: Mori, Yuki, et al.
Publicado: (2017)

Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA
por: Nghiem-Buffet, S, et al.
Publicado: (2017)

Challenging Clinical Cases – A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN(®))
por: Pessoa, Bernardete, et al.
Publicado: (2020)

Successful management of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension with intravitreal ranibizumab
por: Kumar, Nitin, et al.
Publicado: (2018)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda, Sameh Mosaad, et al.
Publicado: (2017)

Intravitreal gas injection for the treatment of diabetic macular edema
por: McHugh, Dominic, et al.
Publicado: (2011)

Idiopathic Macular Telangiectasia Type 1 with Ruptured Retinal Arterial Macroaneurysm Post Intravitreal Bevacizumab
por: Nakhwa, Chinmay P., et al.
Publicado: (2015)

Severe hypotony and filtering bleb leak after intravitreal injection of ranibizumab
por: Georgalas, Ilias, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_n9q6aokrugggnr31jkbm8ucgda